We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA Grants Priority Review to Acadia’s Psychosis Drug Merck Wins Breakthrough Therapy Designation for Keytruda FTC Settles Charges Against Concordia, Par DOJ Subpoenas Vertex over Good Laboratory Practices